T1	intervention 15 42	low-thrombin fibrin sealant
T2	eligibility 669 731	patients undergoing axillary node dissection for breast cancer
T3	No-of-participants 774 779	Sixty
T4	duration 808 844	between September 2012 and June 2013
T5	intervention-participants 860 866	Thirty
T6	control-participants 936 938	30
T7	control 939 953	drainage alone
T8	outcome-Measure 1005 1025	predictors of seroma
T9	outcome-Measure 1065 1075	Lymphedema
T10	outcome 1152 1209	reduced serum output collected in the drain after surgery
T11	outcome 1255 1300	shorter length of postoperative hospital stay
T12	outcome 1314 1333	Incidence of seroma
T13	outcome 1453 1482	predictor of seroma formation
T14	outcome 1695 1705	lymphedema
T15	intervention-value 1722 1726	6.7%
T16	control-value 1730 1733	10%
